Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-06-06 @ 2:01 AM
Study NCT ID:
NCT07454018
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-06
First Post:
2026-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer
Sponsor:
Organization: